A risk-stratified testing strategy employed at Singapore General Hospital (SGH) helped minimize disruption to surgical procedures during the COVID-19 pandemic and reduced virus transmission to healthcare workers (HCWs), a recent study showed.
Patients hospitalized with mild-to-moderate COVID-19 who are on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for hypertension should continue these medications, according to primary results of the BRACE CORONA trial presented at ESC 2020.
In virologically suppressed patients with chronic hepatitis B virus (HBV) infection, switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) did not affect their rates of viral suppression, according to the final 96-week analysis of a phase III study.
Online messaging apps may be helpful in spreading trustworthy information regarding the coronavirus disease 2019 (COVID-19) pandemic, allaying the public’s distress and promoting well-being, according to a recent Singapore study.
There appears to be a higher thrombus burden and poorer outcomes in patients with the novel coronavirus disease (COVID-19) with ST-segment elevation myocardial infarction (STEMI), according to a recent study.
Eight months into the pandemic, the world is still in the heat of fighting a contagion that we’ve no treatment for and no protection from. So far, what we’re able to achieve is a stalemate against COVID-19. Science remains our best hope – a vaccine against SARS-COV-2 with long-lasting protection.
Laboratory and radiological features are insufficient to distinguish the coronavirus disease 2019 (COVID-19) from other non-SARS-CoV-2 respiratory viral infections, according to a new Singapore study. On the other hand, anosmia and dysgeusia are reliable indicators of COVID-19.